Standard v1.1 · by product

Who sells PT-141

18 sellers in the ledger list PT-141 on their own pages. PT-141 is bremelanotide, a peptide approved as the brand Vyleesi and also sold compounded and as a research chemical.

Each record below shows how the seller did on the same eight criteria: a named prescriber, prescription gating, the filling pharmacy, compounding disclosure, testing documents, a business address, a printed price and FDA enforcement. Sellers are listed alphabetically; nothing here is a ranking.

Telehealth services 16

Research vendors 2

Other products in the ledger

SemaglutideTirzepatideLiraglutideSermorelinNAD+GlutathioneGHK-CuTesamorelinBPC-157TB-500MOTS-cSemaxEpitalonIpamorelinCagrilintide

A seller appears here when its own pages listed PT-141 on the date its record was taken. What each criterion requires: the Standard. How checks are performed: method.